Cargando…
Bisimidazolium Salt Glycosyltransferase Inhibitors Suppress Hepatocellular Carcinoma Progression In Vitro and In Vivo
Hepatocellular carcinoma is a leading cause of cancer death, and the disease progression has been related to glycophenotype modifications. Previously synthesized bisimidazolium salts (C20 and C22) have been shown to selectively inhibit the activity of glycosyltransferases in cultured cancer cell hom...
Autores principales: | Luan, Xue, Sun, Ming, Zhao, Xue, Wang, Jingyi, Han, Ye, Gao, Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229238/ https://www.ncbi.nlm.nih.gov/pubmed/35745636 http://dx.doi.org/10.3390/ph15060716 |
Ejemplares similares
-
Dielectric properties of a bisimidazolium salt with dodecyl sulfate anion doped with carbon nanotubes
por: Maximean, Doina Manaila, et al.
Publicado: (2018) -
Selective recognition of ATP by multivalent nano-assemblies of bisimidazolium amphiphiles through “turn-on” fluorescence response
por: Biswas, Rakesh, et al.
Publicado: (2020) -
Carbohydrate scaffolds as glycosyltransferase inhibitors with in vivo antibacterial activity
por: Zuegg, Johannes, et al.
Publicado: (2015) -
Preferential binding of unsaturated hydrocarbons in aryl-bisimidazolium·cucurbit[8]uril complexes furbishes evidence for small-molecule π–π interactions
por: Barrow, Steven J., et al.
Publicado: (2019) -
High-Throughput Screening for Bacterial Glycosyltransferase Inhibitors
por: El Qaidi, Samir, et al.
Publicado: (2018)